Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04141930 · ClinicalTrials.gov registry record · Phase 4
Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 481
- Enrollment target
NCT04141930 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 481 participants.
The verdict
NCT04141930, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 481 participants
- Enrollment target
Study Summary
This study will evaluate a home-based approach to influenza infection control, using prepositioned home-based influenza self-test kits, telemedicine services, and rapid delivery of Xofluza (Baloxavir marboxil) for administration within 48 hours of symptom onset.
Interventions
- DRUG Baloxavir Marboxil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 481 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2020-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04141930
The ClinicalTrials.gov registry entry for NCT04141930 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 481 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baloxavir Marboxil is the first listed.
NCT04141930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04141930 about?
NCT04141930 is a clinical study titled "Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle". This study will evaluate a home-based approach to influenza infection control, using prepositioned home-based influenza self-test kits, telemedicine services, and rapid delivery of Xofluza (Baloxavir marboxil) for administration within 48 hours of symptom onset.
What is the current status of trial NCT04141930?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 481 participants. The study started on 2019-11-01. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT04141930?
The interventions under investigation include: Baloxavir Marboxil (DRUG).
Who is sponsoring clinical trial NCT04141930?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.